Company / AR per Share
ADMA Biologics, Inc. AR per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
$0.67
FY2025
5-year range
$0.08 / $0.67
FY2021-FY2025
Trend
+202.7%
vs FY2024
Sector context
#58 of 115
Health Care
What the data says
AR per Share changed +203% YoY in FY2025, a notable deviation from the 9-year average annual change of +79%.
Based on SEC 10-K filings.
0.67 in FY2025 with a 5-year CAGR of +24.6%.
Improved from $0.12 to $0.67 over the past 2 years.
Health Care sector context is included.
AR per Share over time
Growth rates
- 3-Year CAGR
- +103.7%
- 5-Year CAGR
- +24.6%
- 10-Year CAGR
- -
Sector benchmark
#58 of 115 in Health CareTop 50% of 115This company $0.67 Sector average $27.05
▼
-97.5% below sector average
Key checks
Key Insights
- ADMA Biologics, Inc.'s ar per share has grown for 3 consecutive years.
- In FY2025, ar per share increased 202.7% year-over-year.
- Ranks #58 out of 115 companies in the Health Care sector.
- Lowest ar per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 3.37 (safe zone, above 2.9 threshold)
- Strong profit margin: 46.4%
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.67 | +202.7% |
| FY2024 | $0.22 | +78.9% |
| FY2023 | $0.12 | +56.1% |
| FY2022 | $0.08 | -70.9% |
| FY2021 | $0.27 | +22.1% |
| FY2020 | $0.22 | +198.1% |
| FY2019 | $0.07 | +97.4% |
| FY2018 | $0.04 | -87.4% |
| FY2017 | $0.30 | +216.9% |
| FY2016 | $0.10 | +130.0% |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026